Hydrogen Gas Reduces Lung Scarring in Pulmonary Hypertension Study

Authors
Journal
International Journal of Molecular Sciences
Year
DOI
10.3390/ijms252011010
Study Type
Rat
Outcome
Positive
Peer Reviewed
Yes
Country
Russia
Health Condition
Pulmonary Hypertension
Body System
Respiratory

TL;DR

Breathing in molecular hydrogen (H2) gas appears to reduce lung scarring and inflammation in rats with a disease that mimics human pulmonary hypertension.

Key Finding

Inhaled hydrogen gas reduced mast cell populations and decreased collagen scarring in rat lungs with pulmonary hypertension, suggesting a potential anti-fibrotic mechanism involving immune cell modulation.

Summary

In rats with a lung disease that mimics pulmonary hypertension and fibrosis (scarring), researchers tested whether inhaled hydrogen gas could reduce harmful changes in lung tissue. They found that hydrogen gas reduced the number of mast cells (immune cells that trigger inflammation) in the lungs and decreased the production of proteins that promote scarring, resulting in less collagen buildup and tissue damage compared to untreated rats.

Practical Takeaway

This rat study provides early evidence that hydrogen inhalation may help reduce lung scarring through effects on immune cells, but it is a preliminary animal study with individual variation among subjects. Human studies would be needed to determine whether these findings apply to people with pulmonary hypertension or lung fibrosis.

Abstract (excerpt)

Molecular hydrogen (H2) has antioxidant, anti-inflammatory, and anti-fibrotic effects. In a rat model simulating pulmonary fibrotic changes induced by monocrotaline-induced pulmonary hypertension (MPH), we had previously explored the impact of inhaled H2 on lung inflammation and blood pressure…

Read the full abstract via DOI